Related Experiment Videos
Visual laser ablation of the prostate: a preliminary report
R S Malek1, D M Barrett, J P Dilworth
1Department of Urology, Mayo Clinic, Rochester, Minnesota 55905.
Mayo Clinic Proceedings
|January 1, 1995
Summary
Visual laser ablation of the prostate (VLAP) offers a safe and effective treatment for benign prostatic hyperplasia (BPH) obstruction. Early results show significant symptom improvement and increased urinary flow rates, rivaling traditional methods.
Area of Science:
- Urology
- Minimally Invasive Surgery
Background:
- Benign prostatic hyperplasia (BPH) commonly causes bladder outlet obstruction.
- Transurethral resection of the prostate (TURP) is a standard treatment, but carries risks.
- Visual laser ablation of the prostate (VLAP) emerged as a potential alternative.
Purpose of the Study:
- To present preliminary findings on visual laser ablation of the prostate (VLAP).
- To evaluate the short-term outcomes of VLAP in treating BPH-induced bladder outlet obstruction.
Main Methods:
- A review of 47 men undergoing VLAP for symptomatic BPH between July 1992 and April 1993.
- Utilized Neodymium:yttrium-aluminum-garnet (Nd:YAG) laser energy delivered via lateral-firing probes.
- Outpatient treatment for most patients, with catheterization for 2-10 days post-procedure.
Main Results:
- Follow-up data from 32 patients (mean 5 months) showed improved symptom scores and peak flow rates.
- Extended follow-up (mean 11 months) in 12 patients demonstrated further symptom reduction and near-normal residual volumes.
- Minor perioperative complications were managed conservatively; some patients experienced temporary urinary retention.
Conclusions:
- VLAP appears to be a safe and effective alternative for obstructive BPH.
- Short-term VLAP outcomes are comparable to TURP.
- Further studies are needed to optimize VLAP for larger prostates and assess long-term durability.